Lilly, AstraZeneca End Trials Early

Posted: Updated:
(Image courtesy of Eli Lilly and Co.) (Image courtesy of Eli Lilly and Co.)
INDIANAPOLIS -

A series of trials for a potential Alzheimer's disease treatment being tested by Indianapolis-based Eli Lilly and Co. (NYSE: LLY) and AstraZeneca has been called off. The companies have accepted the recommendation of an independent data monitoring committee to discontinue late-stage trials of lanabecestat. The committee concluded trials involving participants in early stages of the disease and mild cases of the disease, as well as a related extension trial, would all be unlikely to meet primary endpoints.

Lilly Research Labs President Daniel Skovronsky says "the complexity of Alzheimer's disease poses one of the most difficult medical challenges of our time, and we are deeply disappointed for the millions suffering from this devastating disease. We are grateful for the contributions of the study participants and their families and encourage them to consider other Alzheimer's disease clinical trials. Lilly remains dedicated to Alzheimer's disease research as we have been for the last three decades. We won't give up on finding a solution for Alzheimer's patients."

In a press release, the companies point out the studies were not stopped based on safety concerns. Lilly says the discontinuation decision is not expected to create "significant costs."

AstraZeneca IMED Biotech Unit Executive Vice President Menelas Pangalos says "we are saddened by this outcome as our researchers are working tirelessly to find a solution for the many people who are impacted by this devastating disease. We are committed to ensuring our findings can be used to inform further research in the Alzheimer's community, given the importance of finding a treatment for this disease."

You can connect to more about the decision by clicking here.

  • Perspectives

    • The Evolution of Business: From Bottom Line to Value Creation And Impact

      In today's world, consumers want to know how corporations, as a whole, are taking a stand. In fact, customers are 43 percent more likely to purchase a product from a company they know is committed to social value. It's not just consumers pushing this trend. Financial service industry leaders, like KeyBank's Beth Mooney and BlackRock's Larry Fink, are challenging business owners and the C-Suite to rethink their economic impact, environmental footprint and social conscience.

    More

Subscribe

Name:
Company Name:
Email:
Confirm Email:
HTML
INside Edge
Morning Briefing
BigWigs & New Gigs
Life Sciences Indiana
Indiana Connections
INPower
Subscribe
Unsubscribe

Events



  • Most Popular Stories

    • St. Vincent Announces Layoffs

      St. Vincent Health says it has laid off 85 employees throughout the state. In a statement to Inside INdiana Business, St. Vincent cites a rapidly-evolving healthcare environment as a reason for the workforce reduction. 

    • Indy Firm Taps Appirio Exec as CEO

      An Indianapolis-based design and innovation consulting firm has named a new chief executive officer. Studio Science says Steve Pruden, who most recently served as senior vice president of human resources with Indy tech company Appirio, will lead the company.

    • (Image Courtesy: Lilly Oncology)

      Lilly Closes on Mega Acquisition

      Indianapolis-based Eli Lilly and Co. (NYSE: LLY) has completed its acquisition of ARMO BioSciences Inc. of California. The deal, which was valued at approximately $1.6 billion when first announced last month, boosts Lilly's immuno-oncology pipeline. Lilly offered $50 per share of ARMO stock for the company. ARMO's portfolio includes...

    • Rose-Hulman Adds New Major

      Rose-Hulman Institute of Technology students now have another option when choosing a major. The Institute has added a engineering design major which is expected to offer a multidisciplinary experience. Students are enrolled to start the new program in the 2018-2019 school year. 

    • GM recently announced it would invest more than $1 billion in its Fort Wayne Assembly plant.

      Auto Job Fair Coming to Allen County

      General Motors is hiring more than 100 new employees in Fort Wayne. The positions in everything from finance to manufacturing are following a gradually increasing presence in the area for the past few years. In 2016, the company invested $127 million in its casting plant in Bedford and planned to pump an additional $1 billion into the Fort Wayne area over the next few years to double the size of its operation. The expansion of GM’s operations has led to increased business for ...